时空转录学阐明了 fulminant 病毒性心肌炎的发病原因
Huihui Li1, Xueting Chen2,3, James Jiqi Wang1
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, China.
Signal transduction and targeted therapy
|February 9, 2025
概括
发性心肌炎 (FM) 涉及中细胞和免疫细胞,如巨细胞和T细胞. 以IVIG等治疗方法准IFN-γ/Spi1通路显示出对管理这种严重心脏病的承诺.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 发性心肌炎 (FM) 是一种严重的,往往致命的心肌炎症.
- 考克萨基病毒B3 (CVB3) 是病毒性心肌炎的常见原因.
研究的目的:
- 使用转录学阐明CVB3诱导的FM的时空病变发生.
- 确定关键的细胞参与者和参与FM的分子途径.
- 评估针对已识别的途径的治疗策略.
主要方法:
- 在CVB3诱导的FM的小鼠模型中,单核和空间转录组学.
- 在治疗前和治疗后的七个时间点进行了分析.
- 对治疗干预措施的评估,包括IVIG.
主要成果:
- 中细胞是CVB3的早期目标,可以启动巨细胞的激活和炎症.
- 通过Spi1通路,Cd8+效应T细胞和IFN-γ有助于心肌细胞损伤.
- 针对IFN-γ/Spi1轴的向疗法和IVIG在降低死亡率和炎症方面表现出显著的有效性.
结论:
- CVB3诱导的FM涉及中细胞,巨细胞和T细胞的复杂相互作用.
- IFN-γ/Spi1轴是FM中心脏损伤的关键调解器.
- 通过调节病毒载量和高炎症,IVIG显示出治疗潜力.
相关概念视频
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...


